期刊文献+

国产奥沙利铂为主的联合化疗治疗51例晚期大肠癌疗效观察 被引量:5

Clinical Study on Treatment of the Advanced Colon Carcinoma with (Domestic-made) Oxaliplatin
下载PDF
导出
摘要 目的:观察含国产奥沙利铂(L-OHP)的联合方案治疗晚期大肠癌的临床疗效和不良反应。方法:51例晚期大肠癌患者随机分为治疗组和对照组。A组(治疗组):L-OHP130mg/m2,静滴第1天,亚叶酸钙(CF)200mg/m2,静滴第1~5天,氟脲嘧啶脱氧核苷(FUDR)400mg/m2,静滴第1~5天,21天为一个周期;B组(对照组):CF200mg/m2,静滴第1~5天,FUDR400mg/m2,静滴第1~5天,21天为一个周期。2周期后评定疗效。结果:A组26例患者有效率46.2%,不良反应主要为感觉神经毒性,恶心,呕吐和白细胞下降;B组25例患者有效率12.0%,不良反应主要为恶心、呕吐和白细胞下降,无神经毒性。结论:国产L-OHP联合CF+FUDR方案较CF+FUDR方案疗效提高,患者耐受良好,是治疗晚期大肠癌安全有效的方案。 Objective: To observe the efficacy and toxicity of Oxaliplantin in treatment of the advanced colon carcinoma. Methods: Fifity-one patients were enrolled into the study and were divided into two groups. The twenty-six patients of group A (the treatment group) were treated with Oxaliplatin 130mg/m2 on day 1, CF 200mg/m2 on day 1-5, and FUDR 400mg/m2 on day 1-5, respectively. There were 21 days in one cycle. The twenty-five patients of group 2 (the control group) were treated with CF 200mg/m2 on day 1-5 and FUDR 400mg/m2 on day 1-5 also, and there were 21 days in one cycle, too. The efficacy was evaluated two weeks after administration. Results: The efficacy of group A was 46.2%, and the main side-effects were sensory neurotoxicity, nansea, vomiting and drop of white blood cells. The effective rate in group B was 12% and the side-effects were nausea and vomiting, without neurotoxicity. Conclusion: The efficacy of the Oxaliplatin combined with the CF and FUDR in treatment of the advanced colon cancer was better than that of CF and FUDR. only. The patients can tolerate the side-effects well, so it's feasible in clinical treatment.
作者 陆仰东
机构地区 天津市永久医院
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2004年第24期1401-1403,共3页 Chinese Journal of Clinical Oncology
关键词 奥沙利铂 氟脲嘧啶脱氧核苷 大肠癌 化学治疗 Oxaliplatin Carcinoma of colon Chemotheraphy
  • 相关文献

参考文献4

  • 1Fong Y. Surgical therapy of hepatic colorectal metastasis [J]. CA CancerJ Clin, 1999, 49(40):231-255
  • 2Bleiberg H. Oxaliplatin (L-OHP):a new reality in colorectal cabcer [J]. BrJ Cancer, 1998, 77(suppl 4 ):1-3
  • 3Hoff PM, Ansari R, Batist G, et al. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase Ⅲ study [J]. J Clin Oncol 2001, 1
  • 4QUASAR Gollaborative Group: Comparison ot tluorouracfi with additional levamisole. High-dose folinic acid, or both, as adiuvant chemotherapy for colorectal cancer: A randomized trail[J]. Lancet,2000, 355(9215):1588~1596

同被引文献29

  • 1张文,许立功.晚期结直肠癌的化疗进展[J].中国癌症杂志,2004,14(4):378-382. 被引量:25
  • 2应杰儿,钟海均,冯海洋.FOLFOX4方案治疗晚期大肠癌的临床观察[J].肿瘤防治杂志,2005,12(18):1423-1424. 被引量:28
  • 3吴东平,吕杰青,陶锋,王建芳,王松祥.FOLFOX4方案治疗晚期结直肠癌的临床观察[J].肿瘤研究与临床,2006,18(4):255-257. 被引量:6
  • 4李苏宜,刘琳,顾小怡,姜藻,王彩莲,董丽钧,万建平.草酸铂联合氟尿嘧啶、醛氢叶酸治疗晚期结直肠癌的临床观察[J].临床肿瘤学杂志,2006,11(8):612-614. 被引量:8
  • 5Goldstein D, Mitchell P, Michal M, et al. Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer Patients[J]. Br J Cancer,2005, 92(5) :832-837.
  • 6Hsuen Lim E, Seng Cheong Lim R, Seng Wu T, et al. Oxaliplatin/fluorouracil/leucovorin in advanced colorectal carcinoma:an asian experience[J]. Pann Pharmacother,2003,37(12) :1909-1912.
  • 7Kemeny N, Garay C A, Gurtler J, et al. Randomized multicenter phase Ⅱ trial of bolus plus in FU sional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer [J]. J Clin Oncol,2005,23(1) :248-252.
  • 8Parkin D M, Bray F, Ferlay J, et al. Global cancer statistics,2002[J]. CA Cancer J Clin, 2005, 55(2) :74-108.
  • 9Rixe O, Ortuzar W,Alvarez M, et al. Oxaliplatin,tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug resistant celllines and in the cell lines of the National Cancer Institute ' s Anticancer Drug Screen panel[J]. Biochem Pharmacol, 1996,52 (12): 1855 -1865.
  • 10Kuebler J P,de Gramont A. Recent Experience With Oxaliplatin or lrinotecan combined with 5-fluorouracil and leucovorin in the treatment of colorectal cancer[J]. Semin Oncol,2004,30(4 Suppl 15) :40-47.

引证文献5

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部